News & Press: Advocacy

SIS Summarizes and Presents RFA Evidence to Blue Cross and Blue Shield of Louisiana

Thursday, May 9, 2019  
In a May 7, 2019 comment letter, the Spine Intervention Society (SIS) informed Blue Cross and Blue Shield of Louisiana that their coverage policy misclassifies radiofrequency ablation (RFA) of peripheral nerves to treat pain associated with knee osteoarthritis (OA) as investigational.

Under the policy, Ablation of Peripheral Nerves to Treat Pain, patients covered by Louisiana Blue Cross are denied effective, nonsurgical RFA treatments proven to improve patient function and quality of life; decrease dependence on oral pain medications; reduce physical therapy utilization; and spare many future costly and unnecessary surgical interventions.

Acknowledging the strength and quality of the evidence in support of the safety and effectiveness of genicular nerve RFA, the American Medical Association’s Current Procedural Terminology (CPT®) Editorial Panel has approved a Category I code that is expected to go into effect on January 1, 2020.

Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2019 Spine Intervention Society 501(c)( 3) Privacy Policy  ::  Legal